Shares of weight-loss drug developers including Eli Lilly & Co., Novo Nordisk and Structure Therapeutics fell sharply early Wednesday after Roche Holding AG announced early-stage trial data for its experimental obesity pill.
More Stories
What traders are saying about new election-betting rules: ‘I can put money on the candidate I don’t want to win’
Just hours after it began, legal betting on the outcome of U.S. Congressional elections was put on hold by a...
Business started to get back to normal in Q2 — at least for the biggest retailers
Walmart has essentially fashioned itself into “Amazon 2.0,” one analyst says.
The second-largest economy in the world just raised its retirement age. American workers should take notice.
The U.S. is facing a similar retirement crisis, and there’s no easy solution.
Trump social-media stock ‘DJT’ soars as former president says he won’t sell when lockup period ends
Shares of Trump Media & Technology Group Corp. jumped Friday after Republican presidential nominee Donald Trump said he didn’t plan...
NASA astronaut Butch Wilmore doesn’t feel let down by Boeing over Starliner snafu
Astronauts Butch Wilmore and Suni Williams traveled to space in Boeing’s troubled Starliner capsule but will return to Earth in...
U.S. Steel’s stock rises after report Biden won’t block takeover by Nippon anytime soon
U.S. Steel Corp.’s stock jumped on Wednesday afternoon following a report that President Joe Biden will not move imminently to...